$17.54
-1.30 (-6.90%)
Performance
1D
—
1W
—
1M
—
3M
+3.24%
6M
-5.24%
1Y
+53.72%
YTD
-5.19%
Open$18.85
Previous Close$18.84
Day High$18.95
Day Low$17.35
52W High$25.00
52W Low$8.06
Volume—
Avg Volume1.48M
Market Cap2.90B
P/E Ratio—
EPS$-3.54
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$18.16
Below
SMA 200
$14.91
Above
RSI (14)
28.7
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
+457.9% upside
Current
$17.54
$17.54
Target
$97.86
$97.86
$76.65
$97.86 avg
$132.93
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 618.44M | 584.19M | 668.57M |
| Net Income | 86.92M | 95.40M | 98.23M |
| Profit Margin | 14.1% | 16.3% | 14.7% |
| EBITDA | 124.54M | 120.89M | 157.55M |
| Free Cash Flow | 66.24M | 92.85M | 89.99M |
| Rev Growth | +16.5% | -3.4% | +9.6% |
| Debt/Equity | 0.27 | 0.23 | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |